Approval · Notice of Compliance 310 · 2004
IMMUCYST: Notice of Compliance 310
Issued April 1, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 310
- Date
- April 1, 2004
- Company
- Aventis Pasteur LimitedSwiftwater, Pennsylvania, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMMUCYST | Not yet assigned | — |
Medicinal ingredients
- BACILLUS CALMETTE-GUERIN BCG 81 MG per VIAL